AbbVie Announces Positive Results from Phase 3 Trial for Parkinson’s Disease Monotherapy
AbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
Read moreAbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
Read moreIn a groundbreaking leap, researchers have engineered microscopic magnetic robots that could transform the treatment of deadly brain bleeds caused
Read moreGroundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read moreNew Research Highlights the Potential of Vitamin C in Protecting Vision for Glaucoma Patients A Striatech .pdf Case Study OptoDrum,
Read moreSangamo Therapeutics Enters License Agreement with Genentech to Develop Genomic Medicines for Neurodegenerative Diseases Sangamo Therapeutics, Inc., a leader in
Read moreResearchers have devised a novel human 3D model for Alzheimer’s Disease, enabling the study of immune cell involvement in the
Read moreThe Photorefractor is an innovative device designed to automatically measure the refractive state of the eye of small, alert laboratory animals. This
Read moreStriatech’s Keratometer is an innovative device for automated measuring of corneal curvature in alert small laboratory animals. This cutting-edge device
Read moreIn the neurobiology landscape, the Tau protein plays a crucial role in stabilising microtubules within neurons. Positioned primarily in axons
Read moreTakeda has secured an exclusive global option and license agreement for AC Immune’s promising active immunotherapy targeting amyloid beta for
Read more